Terms: = Thyroid cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Prognosis
3 results:
1. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract] [Full Text] [Related]
2. miR-17-5p suppresses cell proliferation and invasion by targeting etv1 in triple-negative breast cancer.
Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
[TBL] [Abstract] [Full Text] [Related]
3. COP1, the negative regulator of etv1, influences prognosis in triple-negative breast cancer.
Ouyang M; Wang H; Ma J; Lü W; Li J; Yao C; Chang G; Bi J; Wang S; Wang W
BMC Cancer; 2015 Mar; 15():132. PubMed ID: 25884720
[TBL] [Abstract] [Full Text] [Related]
